Table 2.
Survivors and non-survivors
| Survivors (n = 65) | Non-survivors (n = 26) | |||
|---|---|---|---|---|
| All (CV +other causes) | CV cause (n = 16) | Other causes (n = 10) | ||
| Age, years | 37.0 ± 13.6 | 55.4 ± 23.2a | 63.0 ± 20.6a | 43.3 ± 22.8c |
| Gender M/F | 37/28 | 18/8 | 11/5 | 7/3 |
| Dialysis vintage, mo | 132 (48, 180) | 84 (63, 105) | 96 (48, 126) | 72 (60,84) |
| Diabetes, n | 5 | 9a | 7a | 2 |
| Hemoglobin, g/dl | 11.7 ± 1.5 | 11.0 ± 1.7 | 11.4 ± 1.7 | 10.6 ± 1.6a |
| Creatinine, mg/dl | 11.6 ± 3.3 | 9.5 ± 2.9a | 9.8 ± 2.6a | 9.0 ± 3.5a |
| Albumin, g/dl | 4.2 ± 0.4 | 4.1 ± 0.6 | 4.1 ± 0.7 | 4.1 ± 0.5 |
| Ferritin, ng/ml | 519 (175, 691) | 570 (278, 902) | 598 (270, 862) | 570 (276,1106) |
| Calcium, mg/dl | 9.1 ± 1.0 | 9.4 ± 1.3 | 9.5 ± 1.6 | 9.4 ± 0.9 |
| Phosphate, mg/dl | 5.4 ± 1.9 | 4.8 ± 1.8 | 5.3 ± 1.9 | 3.9 ± 1.3a |
| AP, U/l | 82 (65, 122) | 81 (68, 127) | 77 (63, 107) | 96 (68,158) |
| PTH, pg/ml | 200 (97, 401) | 133 (77, 229) | 145 (91, 454) | 132 (39,180) |
| Calcitonin, pg/ml | 2.8 (2.0,4.9) | 3.2 (2.0, 5.7) | 2.0 (2.0, 4.82) | 4.6 (2.0, 7.6) |
| β2micro, μg/ml | 28 (22, 34) | 25 (16, 30) | 24 (19, 30) | 30 (12, 45) |
| IL-6, pg/ml | 2.8 (1.4, 4.2) | 3.3 (2.3, 12.7) | 3.0 (2.3, 6.9) | 12.7 (2.0, 27.9)a |
| Klotho, pg/ml | 46.8 (7.6, 82.8) | 15.7 (0.1, 103.0) | 8.7 (0.1, 45.1)b | 114.3 (3.7, 167.7) |
| FGF 23, RU/ml | 134 (122, 159) | 147 (129, 197)a | 150 (129,311)a | 143 (133, 152) |
| Scl, ng/ml | 0.76 (0.50, 1.34) | 1.45 (0.83, 1.79)a | 1.63 (1.20, 1.87)a | 0.84 (0.45, 1.73) |
M: male; F: female; AP: Alkaline Phosphatase; PTH: parathormone; β2micro: β2microglobulin; IL-6: interleucin; FGF 23: fibroblast growth factor; Scl: sclerostin; ap < 0.05 vs. survivors; bp = 0.052 vs. survivors; cp < 0.05 vs. CV cause.